Using AI genetic screening to personalize cancer therapy and improve treatment outcomes.

1. Genetic Screening For
CancerTherapy
by Cambridgene

2. Pain Points
CAMBRID GE NE
Marty
info@cambridgene.com
svastia.ai

3. Why Clinical Trials Fail
CAMBRID GE NE
Get 2M / 6M
Lack Of Patients
Why patients respond
Lack of Data
?
? ?
info@cambridgene.com
svastia.ai

4. Our Solution
AI-driven genetic screening
CAMBRID GE NE
info@cambridgene.com
svastia.ai

5. Cancer Clinical Trials
COST PER TRIAL
$1.4B
9/10
TRIALS FAIL
CAMBRID GE NE
info@cambridgene.com
svastia.ai

6. Our Solution
18%
COST SAVINGS
26%
SUCCESS RATE
CAMBRID GE NE
info@cambridgene.com
svastia.ai

7. Traction
CAMBRID GE NE
CUSTOMERS HOSPITAL PARTNER
info@cambridgene.com
svastia.ai

8. $38B
Market
CAMBRID GE NE
CANCER CLINICAL TRIALS
info@cambridgene.com
svastia.ai

9. Team
CAMBRID GE NE
Parthiban
Vijayarangakannan
CEO
Prem
Achuthan
CTO
Alexey
Larionov
Consultant oncologist
Anusha
Gunasekaran
Cloud/Big Data engineer
info@cambridgene.com
svastia.ai

10. We Offer Hope To Cancer Patients
CAMBRID GE NE
svastia.ai
info@cambridgene.com